Biblio
Human induced pluripotent stem cell-derived closed-loop cardiac tissue for drug assessment. iScience. 2024;27(2):108992.
Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis. JCI Insight. 2019;5.
Human induced pluripotent stem cell-derived GABAergic interneuron transplants attenuate neuropathic pain. Pain. 2020;161(2):379-387.
. Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis. Cell Rep. 2018;24(9):2300-2311.
Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Produce Distinct Neural 3D In Vitro Models Depending on Alginate/Gellan Gum/Laminin Hydrogel Blend Properties. Adv Healthc Mater. 2021:e2100131.
. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype. PLoS One. 2021;16(3):e0245571.
. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on ionic current block effects. Br J Pharmacol. 2015.
. Human induced pluripotent stem cells: A new source for brown and white adipocytes. World J Stem Cells. 2014;6(4):467-72.
. Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate. J Virol. 2024:e0127823.
. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1. PLoS One. 2015;10(5):e0125544.
. Human induced pluripotent stem cells (BIONi010-C) generate tight cell monolayers with blood-brain barrier traits and functional expression of large neutral amino acid transporter 1 (SLC7A5). Eur J Pharm Sci. 2020:105577.
Human induced pluripotent stem cells derived from a patient with a mutation of SERPINC1 c.236G>A (p.R79H). Stem Cell Res. 2023;71:103150.
. Human induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies. Cardiovasc Res. 2020.
. Human Induced Pluripotent Stem Cells for Studying Mitochondrial Diseases in the Heart. FEBS Lett. 2022.
. Human Induced Pluripotent Stem Cells for Tumor Targeted Delivery of Gold Nanorods and Enhanced Photothermal Therapy. ACS Nano. 2016.
Human Induced Pluripotent Stem Cells from Basic Research to Potential Clinical Applications in Cancer. Biomed Res Int. 2013;2013:430290.
. Human induced pluripotent stem cells: From cell origin, genomic stability and epigenetic memory to translational medicine. Stem Cells. 2022.
. . Human induced pluripotent stem cells generate light responsive retinal organoids with variable and nutrient dependent efficiency. Stem Cells. 2018.
Human induced pluripotent stem cells generated from a patient with idiopathic basal ganglia calcification. Stem Cell Res. 2021;53:102274.
Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene. Stem Cell Res. 2022;64:102933.
. Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene. Stem Cell Res. 2022;65:102974.
Human induced pluripotent stem cells (hiPSC), enveloped in elastin-like recombinamers for cell therapy of type 1 diabetes mellitus (T1D): preliminary data. Front Bioeng Biotechnol. 2023;11:1046206.
. .